REBECA KLATT: Open Payments
NPI 1093260564 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 58 payments from 26 companies in 2025. Trend: 2023 $838 · 2024 $1,076 · 2025 $1,296
Food & beverage: $974Education: $322
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $188 |
| PFIZER INC. | 9 | $141 |
| AstraZeneca Pharmaceuticals LP | 4 | $138 |
| Celgene Corporation | 4 | $87 |
| Incyte Corporation | 4 | $77 |
| Genentech USA, Inc. | 3 | $75 |
| SEAGEN INC. | 1 | $75 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| ABBVIE INC. | 2 | $46 |
| ARRAY BIOPHARMA INC | 6 | $38 |
Products named: ENHERTU, REBLOZYL, TUKYSA, OJJAARA, JAKAFI, Tecentriq, DATROWAY, BRAFTOVI.
Industry payments across GA — which companies pay providers there.
